V. Z. Gorkin

655 total citations
65 papers, 471 citations indexed

About

V. Z. Gorkin is a scholar working on Biochemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, V. Z. Gorkin has authored 65 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biochemistry, 23 papers in Molecular Biology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in V. Z. Gorkin's work include Amino Acid Enzymes and Metabolism (18 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Biochemical Acid Research Studies (10 papers). V. Z. Gorkin is often cited by papers focused on Amino Acid Enzymes and Metabolism (18 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Biochemical Acid Research Studies (10 papers). V. Z. Gorkin collaborates with scholars based in Russia, United Kingdom and United States. V. Z. Gorkin's co-authors include A. E. Medvedev, И. Б. Федотова, M.I. Lerman, M. Sandler, Leonid B. Klyashtorin, Vasily A. Yakovlev, Н. К. Уткина, Galina A. Davydova, Vivette Glover and Р. С. Сагитуллин and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

V. Z. Gorkin

57 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Z. Gorkin Russia 13 225 144 134 80 72 65 471
A. D'Iorio Canada 14 344 1.5× 145 1.0× 110 0.8× 150 1.9× 43 0.6× 62 688
J.I. Salach United States 9 242 1.1× 177 1.2× 93 0.7× 35 0.4× 71 1.0× 10 538
Anastasia Constantinescu United States 9 309 1.4× 94 0.7× 186 1.4× 62 0.8× 29 0.4× 14 569
Charles M. McEwen United States 10 371 1.6× 82 0.6× 158 1.2× 165 2.1× 70 1.0× 10 569
Sau‐Wah Kwan United States 13 295 1.3× 182 1.3× 52 0.4× 71 0.9× 27 0.4× 17 571
James Barsky United States 7 224 1.0× 146 1.0× 86 0.6× 100 1.3× 47 0.7× 8 635
Carvell H. Williams United Kingdom 12 332 1.5× 236 1.6× 63 0.5× 229 2.9× 39 0.5× 31 714
Martin P. Schulman United States 14 363 1.6× 164 1.1× 99 0.7× 110 1.4× 11 0.2× 27 717
H. Balzer Germany 15 282 1.3× 158 1.1× 58 0.4× 95 1.2× 10 0.1× 35 538
Yung‐Feng Chang United States 16 447 2.0× 191 1.3× 204 1.5× 84 1.1× 52 0.7× 34 721

Countries citing papers authored by V. Z. Gorkin

Since Specialization
Citations

This map shows the geographic impact of V. Z. Gorkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Z. Gorkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Z. Gorkin more than expected).

Fields of papers citing papers by V. Z. Gorkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Z. Gorkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Z. Gorkin. The network helps show where V. Z. Gorkin may publish in the future.

Co-authorship network of co-authors of V. Z. Gorkin

This figure shows the co-authorship network connecting the top 25 collaborators of V. Z. Gorkin. A scholar is included among the top collaborators of V. Z. Gorkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Z. Gorkin. V. Z. Gorkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorkin, V. Z., et al.. (1994). Antiseizure effecdt of isatin and reduction of monamine oxidase activity in rats with experimental audiogenic seizures. Medical science research. 22(8). 555–556. 5 indexed citations
2.
Medvedev, A. E. & V. Z. Gorkin. (1994). Endogenous stimulation of lipid peroxidation in brain increases proteolytic‐inactivation of mitochondrial monoamine oxidases. International Journal of Developmental Neuroscience. 12(2). 151–155. 7 indexed citations
3.
Medvedev, A. E., et al.. (1994). MONOAMINE OXIDASE INHIBITORS AS ANTICONVULSANTS. 71. 400–400. 3 indexed citations
4.
Gorkin, V. Z., et al.. (1993). Lipid peroxidation affects catalytic properties of rat liver mitochondrial monoamine oxidases and their sensitivity to proteolysis. International Journal of Biochemistry. 25(12). 1791–1799. 8 indexed citations
5.
Medvedev, A. E., et al.. (1992). Efficacy of pirlindole, a highly selective reversible inhibitor of monoamine oxidase type A, in the prevention of experimentally induced epileptic seizures. Clinical Drug Investigation. 4(6). 501–507. 3 indexed citations
6.
Medvedev, A. E., et al.. (1992). The role of lipid peroxidation in the possible involvement of membrane-Bound monoamine oxidases in gamma-aminobutyric acid and glucosamine deamination in rat brain. Molecular and Chemical Neuropathology. 16(1-2). 187–201. 13 indexed citations
7.
8.
Gorkin, V. Z., et al.. (1990). Some Neurobiological Mechanisms of the Effect of Ethanol on Offspring of Chronically Alcohol Treated Rats. Annals of Medicine. 22(5). 353–356. 4 indexed citations
9.
Gorkin, V. Z., et al.. (1990). Aaptamine-new selective inhibitor of type a monoamine oxidases. Pharmaceutical Chemistry Journal. 24(7). 456–458. 7 indexed citations
10.
Gorkin, V. Z., et al.. (1982). Kinetic properties of multiple forms of mono amine oxidase ec 1.4.3.4 from bovine brain. 28(5). 127–131.
11.
Gorkin, V. Z., et al.. (1973). Normalization by nucleotides of impairments in deamination of nitrogenous compounds in liver of tumor-bearing mice. Cellular and Molecular Life Sciences. 29(1). 22–23. 1 indexed citations
12.
Gorkin, V. Z., et al.. (1972). Induced appearance of adenylate-deaminating activity in highly purified bovine liver mitochondrial monoamine oxidase. Biochimica et Biophysica Acta (BBA) - Enzymology. 289(1). 44–56. 2 indexed citations
13.
Gorkin, V. Z., et al.. (1972). Mitochondrial monoamine oxidase of rat liver: Reversible qualitative alterations in catalytic properties. Biochimica et Biophysica Acta (BBA) - Enzymology. 258(1). 56–70. 21 indexed citations
14.
Gorkin, V. Z., et al.. (1971). Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases. Biochemical Pharmacology. 20(10). 2571–2577. 4 indexed citations
15.
Gorkin, V. Z.. (1971). Monoamine oxidase activity in membrane structures of rat liver cell. Cellular and Molecular Life Sciences. 27(1). 30–30. 12 indexed citations
16.
Gorkin, V. Z., et al.. (1971). Effects of monoamine oxidase inhibitors on qualitative alterations (‘Transformation’) of the catalytic properties of amine oxidases. Biochemical Journal. 121(3). 31P–32P. 3 indexed citations
17.
Gorkin, V. Z., et al.. (1969). [On the possibility of "transplantation " of mitochondrial monoamine oxidase into a diamine oxidase-like enzyme in vivi].. PubMed. 14(5). 538–40. 2 indexed citations
18.
Gorkin, V. Z., et al.. (1966). Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase. Cellular and Molecular Life Sciences. 22(3). 157–157. 10 indexed citations
19.
Gorkin, V. Z.. (1966). Monoamine oxidases.. PubMed. 18(1). 115–20. 11 indexed citations
20.
Gorkin, V. Z., et al.. (1964). The inhibition of mitochondrial amine oxidases in vitro by proflavine. Biochemical and Biophysical Research Communications. 15(4). 383–389. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. D'Iorio Breakdown of academic impact, for papers by J.I. Salach Breakdown of academic impact, for papers by Anastasia Constantinescu Breakdown of academic impact, for papers by Charles M. McEwen Breakdown of academic impact, for papers by Sau‐Wah Kwan Breakdown of academic impact, for papers by James Barsky Breakdown of academic impact, for papers by Carvell H. Williams Breakdown of academic impact, for papers by Martin P. Schulman Breakdown of academic impact, for papers by H. Balzer Breakdown of academic impact, for papers by Yung‐Feng Chang
Rankless by CCL
2026